Equifax (NYSE:EFX) Stock Price Down 12.2% – Should You Sell?

Equifax, Inc. (NYSE:EFX)’s share price traded down 12.2% on Tuesday . The stock traded as low as $173.83 and last traded at $174.7720. 1,390,710 shares traded hands during trading, a decline of 17% from the average session volume of 1,678,469 shares. The stock had previously closed at $199.17.

Key Headlines Impacting Equifax

Here are the key news stories impacting Equifax this week:

• Positive Sentiment: Q4 beat and revenue growth — Equifax reported Q4 2025 EPS and revenue above consensus, with revenue up ~9% year‑over‑year and management citing cloud and AI as drivers of new product innovation and record‑high product activity. This underpins the upside case on durable end markets (workforce, USIS). Equifax Delivers Fourth Quarter 2025 Revenue Growth of 9%
• Positive Sentiment: Product/market catalysts — Management highlighted VantageScore traction and AI/cloud leverage (90% of revenue on the new Equifax Cloud) as enablers for faster product rollout and efficiency, supporting mid/long‑term growth expectations. Equifax sees VantageScore traction build, targets strong growth in 2026
• Positive Sentiment: Commercial partnerships — Equifax expanded a partnership to deliver broader consumer financial solutions, signaling cross‑sell and distribution opportunities that can help monetize product innovation. Gen and Equifax Expand Partnership
• Neutral Sentiment: Analysts trim targets but keep positive ratings — Several firms lowered price targets after the results (JPM: $260→$230; Wells Fargo: $265→$240; RBC: $250→$222; Needham: $295→$265), yet many maintained Overweight/Outperform/Buy ratings, leaving meaningful upside in their models. This suggests updated estimates rather than a change in conviction. These Analysts Cut Their Forecasts On Equifax After Q4 Earnings
• Negative Sentiment: Cautious near‑term guidance — Equifax set Q1 2026 EPS guidance of $1.63–1.73, below the prior consensus (~$1.78), which pressures near‑term expectations and partly explains analyst PT reductions. Equifax Q4 Earnings Beat Estimates, Revenues Jump 9% Y/Y
• Negative Sentiment: Regulatory/reputational risk — U.S. senators publicly accused Equifax of “price‑gouging” related to Medicaid programs, drawing scrutiny that could create contract or pricing headwinds in government work. This has already pressured the stock in prior sessions. Senators Accuse Equifax of ‘Price‑Gouging’ Medicaid Programs

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Oppenheimer lowered their price target on Equifax from $271.00 to $266.00 and set an “outperform” rating on the stock in a report on Monday, January 12th. Needham & Company LLC decreased their target price on shares of Equifax from $295.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday. Wells Fargo & Company lowered their target price on shares of Equifax from $265.00 to $240.00 and set an “overweight” rating on the stock in a research note on Thursday. UBS Group set a $230.00 price target on shares of Equifax in a research report on Thursday. Finally, Morgan Stanley decreased their price objective on shares of Equifax from $269.00 to $244.00 and set an “overweight” rating for the company in a report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $242.64.

Equifax Stock Performance

The company’s 50-day moving average price is $213.11 and its two-hundred day moving average price is $228.02. The company has a market cap of $23.33 billion, a P/E ratio of 35.83, a price-to-earnings-growth ratio of 1.87 and a beta of 1.55. The company has a current ratio of 0.60, a quick ratio of 0.74 and a debt-to-equity ratio of 0.88.

Equifax (NYSE:EFX) last released its earnings results on Wednesday, February 4th. The credit services provider reported $2.09 EPS for the quarter, beating the consensus estimate of $2.05 by $0.04. The business had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.53 billion. Equifax had a net margin of 10.87% and a return on equity of 19.27%. The business’s quarterly revenue was up 9.3% on a year-over-year basis. During the same period in the prior year, the business earned $2.12 earnings per share. Equifax has set its FY 2026 guidance at 8.300-8.700 EPS and its Q1 2026 guidance at 1.630-1.730 EPS. As a group, equities analysts forecast that Equifax, Inc. will post 7.58 earnings per share for the current year.

Institutional Investors Weigh In On Equifax

Institutional investors and hedge funds have recently modified their holdings of the stock. Country Trust Bank purchased a new position in Equifax in the 2nd quarter worth about $26,000. Ameritas Advisory Services LLC acquired a new position in shares of Equifax in the second quarter worth about $31,000. Caldwell Trust Co acquired a new position in shares of Equifax in the second quarter worth about $33,000. Spire Wealth Management increased its position in shares of Equifax by 82.9% in the third quarter. Spire Wealth Management now owns 128 shares of the credit services provider’s stock worth $33,000 after acquiring an additional 58 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in shares of Equifax during the third quarter valued at approximately $34,000. 96.20% of the stock is owned by institutional investors and hedge funds.

About Equifax

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.